These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38477253)

  • 21. De Novo Synthesis and Structural Elucidation of CDR-H3 Loop Mimics.
    Zhao G; Richaud AD; Williamson RT; Feig M; Roche SP
    ACS Chem Biol; 2024 Jul; 19(7):1583-1592. PubMed ID: 38916527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systematic classification of CDR-L3 in antibodies: implications of the light chain subtypes and the VL-VH interface.
    Kuroda D; Shirai H; Kobori M; Nakamura H
    Proteins; 2009 Apr; 75(1):139-46. PubMed ID: 18798566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Germline-Dependent Antibody Paratope States and Pairing Specific V
    Fernández-Quintero ML; Kroell KB; Bacher LM; Loeffler JR; Quoika PK; Georges G; Bujotzek A; Kettenberger H; Liedl KR
    Front Immunol; 2021; 12():675655. PubMed ID: 34447370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AbFlex: designing antibody complementarity determining regions with flexible CDR definition.
    Jeon W; Kim D
    Bioinformatics; 2024 Mar; 40(3):. PubMed ID: 38449295
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibodies as a model system for comparative model refinement.
    Sellers BD; Nilmeier JP; Jacobson MP
    Proteins; 2010 Aug; 78(11):2490-505. PubMed ID: 20602354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Roles of the respective loops at complementarity determining region on the antigen-antibody recognition.
    Osajima T; Hoshino T
    Comput Biol Chem; 2016 Oct; 64():368-383. PubMed ID: 27591792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Automated identification of complementarity determining regions (CDRs) reveals peculiar characteristics of CDRs and B cell epitopes.
    Ofran Y; Schlessinger A; Rost B
    J Immunol; 2008 Nov; 181(9):6230-5. PubMed ID: 18941213
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conformational changes in antibody Fab fragments upon binding and their consequences on the performance of docking algorithms.
    Barozet A; Bianciotto M; Siméon T; Minoux H; Cortés J
    Immunol Lett; 2018 Aug; 200():5-15. PubMed ID: 29885326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular dynamics simulation of a high-affinity antibody-protein complex: the binding site is a mosaic of locally flexible and preorganized rigid regions.
    Sinha N; Smith-Gill SJ
    Cell Biochem Biophys; 2005; 43(2):253-73. PubMed ID: 16049350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibody humanization by redesign of complementarity-determining region residues proximate to the acceptor framework.
    Hanf KJ; Arndt JW; Chen LL; Jarpe M; Boriack-Sjodin PA; Li Y; van Vlijmen HW; Pepinsky RB; Simon KJ; Lugovskoy A
    Methods; 2014 Jan; 65(1):68-76. PubMed ID: 23816785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A computational approach for studying antibody-antigen interactions without prior structural information: the anti-testosterone binding antibody as a case study.
    Koivuniemi A; Takkinen K; Nevanen T
    Proteins; 2017 Feb; 85(2):322-331. PubMed ID: 27936519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigation of shape variations in the antibody binding site by molecular dynamics computer simulation.
    de la Cruz X; Mark AE; Tormo J; Fita I; van Gunsteren WF
    J Mol Biol; 1994 Mar; 236(4):1186-95. PubMed ID: 8120895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CDR-H3 diversity is not required for antigen recognition by synthetic antibodies.
    Persson H; Ye W; Wernimont A; Adams JJ; Koide A; Koide S; Lam R; Sidhu SS
    J Mol Biol; 2013 Feb; 425(4):803-11. PubMed ID: 23219464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Humanization by CDR grafting and specificity-determining residue grafting.
    Kim JH; Hong HJ
    Methods Mol Biol; 2012; 907():237-45. PubMed ID: 22907355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential aggregation-prone regions in complementarity-determining regions of antibodies and their contribution towards antigen recognition: a computational analysis.
    Wang X; Singh SK; Kumar S
    Pharm Res; 2010 Aug; 27(8):1512-29. PubMed ID: 20422267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coevolved Canonical Loops Conformations of Single-Domain Antibodies: A Tale of Three Pockets Playing Musical Chairs.
    Gaudreault F; Corbeil CR; Purisima EO; Sulea T
    Front Immunol; 2022; 13():884132. PubMed ID: 35720356
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hiding in plain sight: structure and sequence analysis reveals the importance of the antibody DE loop for antibody-antigen binding.
    Kelow SP; Adolf-Bryfogle J; Dunbrack RL
    MAbs; 2020; 12(1):1840005. PubMed ID: 33180672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibody CDR loops as ensembles in solution vs. canonical clusters from X-ray structures.
    Fernández-Quintero ML; Heiss MC; Pomarici ND; Math BA; Liedl KR
    MAbs; 2020; 12(1):1744328. PubMed ID: 32264741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of a high-affinity human antibody with a disulfide bridge in the third complementarity-determining region of the heavy chain.
    Almagro JC; Raghunathan G; Beil E; Janecki DJ; Chen Q; Dinh T; LaCombe A; Connor J; Ware M; Kim PH; Swanson RV; Fransson J
    J Mol Recognit; 2012 Mar; 25(3):125-35. PubMed ID: 22407976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toward high-resolution homology modeling of antibody Fv regions and application to antibody-antigen docking.
    Sivasubramanian A; Sircar A; Chaudhury S; Gray JJ
    Proteins; 2009 Feb; 74(2):497-514. PubMed ID: 19062174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.